June 30, 2021 – Speaking with Maria Bartiromo on Fox Business News, Dr. Roger Crystal, CEO of Opiant Pharmaceuticals and inventor of the NARCAN® nasal spray, says the best way to combat the opioid epidemic is to reduce demand and previews a new opioid rescue medicine.
May 20, 2021 – Opiant CEO Roger Crystal speaks Stuart Varney on Fox Business about the need to confront an opioid epidemic now more deadly from illicit synthetic opioids, incl. fentanyl.
Although the opioid crisis has resulted in close to 600,000 deaths since 1999, evidence shows that increasing the availability of naloxone—a prescription medication that reverses the respiratory depression caused by an opioid overdose—reduces the rate of opioid overdose deaths.
April 19, 2021 – Opiant CEO Roger Crystal on The Watch List to discuss the state of the opioid crisis and an overview of Opiant’s mission to treat addictions and drug overdose.
Opiant donates to organizations supporting patients vulnerable to substance use disorders during COVID-19
Opiant donated $40,000 to the International Association of Fire Fighters Foundation, the Association of Recovery in Higher Education, the Harm Reduction Coalition and the UK’s Action on Addiction.
April 14, 2020 – Roger Crystal set out to impact healthcare at a ‘societal’ level. The doctor who developed the NARCAN® Nasal Spray says he is proud to see its impact on the opioid crisis in the United States: the opioid overdose reversal medicine has saved a large number of lives.
Cannabinoid1 (CB‐1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose
Published in 2020 by the Journal of Neural Transmission.
August 21, 2019 – Opiant CEO Roger Crystal on Stateside i24News discusses the fight on the opioid crisis.